Ceforanide

Chemical formula: C₂₀H₂₁N₇O₆S₂  Molecular mass: 519.554 g/mol  PubChem compound: 43507

Therapeutic indications

Ceforanide is indicated for:

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
at least one of
Musculoskeletal infective disorder
Osteomyelitis
and additionally Staphylococcus aureus

Staphylococcal arthritis and polyarthritis
Acute and subacute infective endocarditis and additionally Staphylococcus aureus

Respiratory tract infection and additionally at least one of
Staphylococcus aureus
Streptococcus pneumoniae
Klebsiella pneumoniae
Haemophilus influenzae

Pneumonia due to Klebsiella pneumoniae
Pneumonia due to staphylococcus
Pneumonia due to streptococcus, group B
Pneumonia due to other streptococci
Bacteremia and additionally at least one of
Staphylococcus aureus
Streptococcus pneumoniae

Infection of skin and additionally at least one of
Staphylococcus aureus
Streptococcus agalactiae
Streptococcus pyogenes
Escherichia coli
Proteus mirabilis
Klebsiella pneumoniae

Urinary tract infectious disease and additionally at least one of
Escherichia coli
Proteus mirabilis
Klebsiella pneumoniae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only children (1 year - 12 years old)

at least one of
at least one of
Musculoskeletal infective disorder
Osteomyelitis
and additionally Staphylococcus aureus

Staphylococcal arthritis and polyarthritis
Acute and subacute infective endocarditis and additionally Staphylococcus aureus

Respiratory tract infection and additionally at least one of
Staphylococcus aureus
Streptococcus pneumoniae
Klebsiella pneumoniae
Haemophilus influenzae

Pneumonia due to Klebsiella pneumoniae
Pneumonia due to staphylococcus
Pneumonia due to streptococcus, group B
Pneumonia due to other streptococci
Bacteremia and additionally at least one of
Staphylococcus aureus
Streptococcus pneumoniae

Infection of skin and additionally at least one of
Staphylococcus aureus
Streptococcus agalactiae
Streptococcus pyogenes
Escherichia coli
Proteus mirabilis
Klebsiella pneumoniae

Urinary tract infectious disease and additionally at least one of
Escherichia coli
Proteus mirabilis
Klebsiella pneumoniae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Preventive procedure and additionally Surgical procedure

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈